Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2011; 17(21): 2674-2680
Published online Jun 7, 2011. doi: 10.3748/wjg.v17.i21.2674
Published online Jun 7, 2011. doi: 10.3748/wjg.v17.i21.2674
Figure 3 Periostin siRNA inhibited nicotine-promoted cell growth in gastric cancer cells.
SGC-7901 cells with stable expression of siRNA-periostin (siRNA-P) and vacant siRNA-control (siRNA-C) were treated with nicotine. Cells were then lysed to analyze cell viability using the methylthiazolyldiphenyl-tetrazolium bromide assay at 0, 24, 48, and 72 h of treatment, and growth curves were constructed. The viability of the siRNA-C+nicotine group was significantly higher than those of the other three groups at the 48 and 72 h time points (P < 0.05), which is indicated by “a”. Notes: siRNA-C: vacant siRNA-control; siRNA-P transfected with periostin.
- Citation: Liu Y, Liu BA. Enhanced proliferation, invasion, and epithelial-mesenchymal transition of nicotine-promoted gastric cancer by periostin. World J Gastroenterol 2011; 17(21): 2674-2680
- URL: https://www.wjgnet.com/1007-9327/full/v17/i21/2674.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i21.2674